All donations up to $200,000 matched before June 30 Donate
A comprehensive, neutral analysis of the global cancer cell therapy landscape; 753 cancer cell therapies in the global development pipeline, with 375 in clinical studies
30 days of education and awareness programming for patients, caregivers, and the public about cancer immunotherapy and clinical trials
Cancer Research Institute iAtlas Poised to Improve Patient Outcomes by Providing Researchers Greater Access to Genomics Data
Two leading non-profits combine efforts to accelerate cancer immunotherapy for patients globally
First-of-its-kind analysis of the global immuno-oncology clinical landscape from pre-clinical development to regulatory approval provides unprecedented opportunity to advance the field of immuno-oncology to improve patient care.
Cancer Research Institute | National Headquarters 29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Cancer Research Institute held its annual Through the Kitchen benefit party yesterday evening and raised $1.4 million to fund six promising postdoctoral fellows over three years.
A second CAR T cell immunotherapy targeting the CD19 receptor was approved by the FDA for patients with relapsed or refractory large B cell lymphoma.